ERYtech Pharma’s encapsulation process is performed in accordance with cell therapy and good transfusion practices.

Encapsulation of therapeutic molecules into erythrocytes is performed using the patients’ own blood or donor’s blood when patients suffer from anemia. Regardless of the source all, blood is qualified by the national blood bank to ensure compliance with transfusion regulations.

Why use red blood cells as a vehicle for therapeutic agents?

Red blood cells are a natural and unique vehicle for drugs due to:

• The Absence of a nucleus, which avoids cell division,
• Natural and total biocompatibility,
• Complete & well-known biodegradability,
• An Adjustable in vivo half life,
• The ability to Encapsulate molecules or enzymes.

ERYtech Pharma respects and uses red blood cell properties to develop innovative therapies.